Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) went down by -4.07% from its latest closing price compared to the recent 1-year high of $9.00. The company’s stock price
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) went up by 7.06% from its latest closing price compared to the recent 1-year high of $9.00. The company’s stock price
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) went up by 9.94% from its latest closing price compared to the recent 1-year high of $9.00. The company’s stock price
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) went up by 49.26% from its latest closing price compared to the recent 1-year high of $9.00. The company’s stock price
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) went down by -4.41% from its latest closing price compared to the recent 1-year high of $9.00. The company’s stock price
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) went down by -9.31% from its latest closing price compared to the recent 1-year high of $9.00. The company’s stock price
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) went down by -5.57% from its latest closing price compared to the recent 1-year high of $9.00. The company’s stock price
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) went down by -7.77% from its latest closing price compared to the recent 1-year high of $9.00. The company’s stock price
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) went up by 12.64% from its latest closing price compared to the recent 1-year high of $7.45. The company’s stock price
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) went up by 39.89% from its latest closing price compared to the recent 1-year high of $7.45. The company’s stock price
© 2021 All rights reserved​
